Malignant paraganglioma caused by a novel germline mutation of the succinate dehydrogenase D-gene - A case report

Head and Neck

Volumn 30, Issue 7, 2008, Pages 964-969

  Papaspyrou, Konstantinos ^a   Rossmann, Heidi ^a   Fottner, Christian ^a   Weber, Matthias M ^a   Mann, Wolf ^a   Lackner, Karl J ^a   Helling, Kai ^a  

^a JOHANNES GUTENBERG UNIVERSITY   (Germany)

Author keywords

18Fluoro Dopa PET; Heredity; Malignant paraganglioma; Pheochromocytoma; Succinate dehydrogenase

Indexed keywords

CATECHOLAMINE; SUCCINATE DEHYDROGENASE; TUMOR MARKER;

ADULT; ANGIOGRAPHY; ARTICLE; ARTIFICIAL EMBOLISM; AUDIOMETRY; CASE REPORT; CATECHOLAMINE EXCRETION; CHEMODECTOMA; COMPUTER ASSISTED TOMOGRAPHY; DYSPHAGIA; GENE MUTATION; GENE SEQUENCE; GERMLINE MICRONUCLEUS; HEARING IMPAIRMENT; HEARING LOSS; HEMANGIOMA; HISTOLOGY; HOARSENESS; HUMAN; IMMUNOHISTOCHEMISTRY; LIVER METASTASIS; LUNG METASTASIS; MALE; NUCLEAR MAGNETIC RESONANCE IMAGING; PHYSICAL EXAMINATION; PRIORITY JOURNAL; SEQUENCE ANALYSIS; THORAX RADIOGRAPHY; TINNITUS; WHOLE BODY SCINTISCANNING;

ADULT; BIOPSY, NEEDLE; GENETIC PREDISPOSITION TO DISEASE; GERM-LINE MUTATION; HUMANS; IMMUNOHISTOCHEMISTRY; MALE; NEOPLASM STAGING; PARAGANGLIOMA; PEDIGREE; POSITRON-EMISSION TOMOGRAPHY; RISK ASSESSMENT; SKULL BASE NEOPLASMS; SUCCINATE DEHYDROGENASE; TREATMENT REFUSAL;

EID: 47549087572     PISSN: 10433074     EISSN: 10970347     Source Type: Journal    
DOI: 10.1002/hed.20746     Document Type: Article

References (31)

1. Milunsky JM, Maher TA, Michels W, Milunsky A. Novel mutations and the emergence of a common mutation in the SDHD gene causing familial paraganglioma. Am J Med Genet 2001;100:311-314.
2. Mills SE, Gaffey MJ, Frierson HF Jr. Tumors of the upper aerodigestive tract and ear. In: Atlas of tumor pathology, Series 3, fasc 26. Washington, DC: Armed Forces Institute of Pathology; 2000.
3. Baysal BE, Farr JE, Rubinstein WS, et al. Fine mapping of an imprinted gene for familial nonchromaffin paragangliomas, on chromosome 11q23. Am J Hum Genet 1997;60:121-132.
4. Manolidis S, Shohet JA, Jackson CG, Glasscock ME III. Malignant glomus tumors. Laryngoscope 1999;109:30-34.
5. Lee JH, Barich F, Karnell LH, et al. National Cancer Data Base report on malignant paragangliomas of the head and neck. Cancer 2002;94:730-737.
6. Baysal BE, Ferrell RE, Willett-Brozick JE, et al. Mutations in SDHD, a mitochondrial complex II gene, in hereditary paraganglioma. Science 2000;287:848-851.
7. Niemann S, Müller U. Mutations in SDHC cause autosomal dominant paraganglioma, type 3. Nat Genet 2000;26:268-270.
8. Astuti D, Latif F, Dallol A, et al. Gene mutations in the succinate dehydrogenase subunit SDHB cause susceptibility to familial pheochromocytoma and to familial paraganglioma. Am J Hum Genet 2001;69:49-54.
9. Baysal BE. Hereditary paraganglioma targets diverse paraganglia. J Med Genet 2002;39:617-622.
10. Young AL, Baysal BE, Deb A, Young WF Jr. Familial malignant catecholamine-secreting paraganglioma with prolonged survival associated with mutation in the succinate dehydrogenase B gene. J Clin Endocrinol Metab 2002;87:4101-4105.
11. Benn D, Croxson M, Tucker K, et al. Novel succinate dehydrogenase subunit B (SDHB) mutations in familial pheochromocytomas and paragangliomas, but an absence of somatic SDHB mutations in sporadic pheochromocytomas. Oncogene 2003;22:1358-1364.
12. Gimenez-Roqueplo AP, Favier J, Rustin P, et al. Mutations in the SDHB gene are associated with extra-adrenal and/or malignant phaeochromocytomas. Cancer Res 2003; 63:5615-5621.
13. van der Mey AG, Maaswinkel-Mooy PD, Cornelisse CJ, Schmidt PH, van de Kamp JJ. Genomic imprinting in hereditary glomus tumours: evidence for new genetic theory. Lancet 1989;2:1291-1294.
14. Hensen EF, Jordanova ES, van Minderhout IJ, et al. Somatic loss of maternal chromosome 11 causes parent-of-origin-dependent inheritance in SDHD-linked paraganglioma and phaeochromocytoma families. Oncogene 2004;23:4076-4083.
15. Margetts CD, Astuti D, Gentle DC, Cooper WN, Cascon A, Catchpoole D, Robledo M, Neumann HP, Latif F, Maher ER. Epigenetic analysis of HIC1, CASP8, FLIP, TSP1, DCR1, DCR2, DR4, DR5, KvDMR1, H19 and preferential 11p15.5 maternal-allele loss in von Hippel-Lindau and sporadic phaeochromocytomas. Endocr Relat Cancer 2005;12:161-172.
16. Gottlieb E, Tomlinson IP. Mitochondrial tumour suppressors: a genetic and biochemical update. Rev Cancer 20055:857-866.
17. Gimm O. Pheochromocytoma-associated syndromes: genes, proteins and functions of RET, VHL and SDHx. Familial Cancer 2005;4:17-23.
18. Maxwell PH. A common pathway for genetic events leading to pheochromocytoma. Cancer Cell 2005;8:91-93.
19. Cole JM, Beiler D. Long-term results of treatment of glomus jugulare and glomus vagale tumors with radiotherapy. Laryngoscope 1994;104:1461-1465.
20. Foote RL, Pollock BE, Gorman DA, et al. Glomus jugulare tumor: tumor control and complications after stereotactic radiosurgery. Head Neck 2002;24:332-338.
21. Renard L, Godfraind C, Boon LM, Vikkula M. A novel mutation in the SDHD gene in a family with inherited paragangliomas-implications of genetic diagnosis for follow-up and treatment. Head Neck 2003;25:146-151.
22. Neumann HPH, Pawlu C, Peczkowska M, et al. Distinct clinical features of paraganglioma syndromes associated with SDHB and SDHD gene mutations. JAMA 2004;292:943-951.
23. Neumann HPH, Bausch B, McWhinney SR, et al. Germline mutations in nonsyndromic pheochromocytoma. N Engl J Med 2002;346:1459-1466.
24. Taschner PE, Jansen JC, Baysal BE, et al. Nearly all hereditary paragangliomas in the Netherlands are caused by two founder mutations in the SDHD gene. Genes Chromosomes Cancer 2001;31:274-281.
25. Gimenez-Roqueplo AP, Favier J, Rustin P, et al. The R22X mutation of the SDHD gene in hereditary paraganglioma abolishes the enzymatic activity of complex II in the mitochondrial respiratory chain and activates the hypoxia pathway. Am J Hum Genet 2001;69:1186-1197.
26. Masuoka J, Brandner S, Paulus W, et al. Germline SDHD mutation in paraganglioma of the spinal cord. Oncogene 2001;20:5084-5086.
27. Benn DE, Gimenez-Roqueplo AP, Reilly JR, et al. Clinical presentation and penetrance of pheochromocytoma/ paraganglioma syndromes. J Clin Endocrinol Metab 2006;91:827-836.
28. Astrom K, Cohen JE, Willett-Brozick JE, Aston CE, Baysal BE. Altitude is a phenotypic modifier in hereditary paraganglioma type 1: evidence for an oxygen-sensing defect. Hum Genet 2003;113:228-237.
29. Havekes B, Corssmit EPM, Jansen JC, van der Mey AGL, Vriends AHJT, Romijn JA Malignant paragangliomas associated with mutations in the succinate dehydrogenase D gene. J Clin Endocrinol Metab 2007;92:1245-1248.
30. Amar L, Bertherat J, Baudin E, et al. Genetic testing in pheochromocytoma or functional paraganglioma. J Clin Oncol 2005;23:8812-8818.
31. Hoegerle S, Ghanem N, Altehoefer C, et al. 18F-DOPA positron emission tomography for the detection of glomus tumours. Eur J Nucl Med Mol Imaging 2003;30:689-694.